These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6886279)

  • 1. A survey of generic drug legislation and geriatric pharmacotherapy: opinions of those who generate the literature.
    Morgan JP; Schwartz LL; Sherman FT
    J Am Geriatr Soc; 1983 Sep; 31(9):535-9. PubMed ID: 6886279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of economic effects of drug product selection legislation.
    Goldberg T; DeVito CA; Smith D; Stano M; Vidis JS; Moore WE; Dickson WM
    Med Care; 1979 Apr; 17(4):411-9. PubMed ID: 431151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opinions of pharmacy, medicine, and pharmaceutical industry leaders about hypothetical therapeutic-interchange legislation.
    Segal R; Grines LL; Pathak DS
    Am J Hosp Pharm; 1988 Mar; 45(3):570-7. PubMed ID: 3369459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of pharmacists' opinions, attitudes and experiences with generic drugs and generic substitution in the Czech Republic.
    Maly J; Dosedel M; Kubena A; Vlcek J
    Acta Pol Pharm; 2013; 70(5):923-31. PubMed ID: 24147373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Ohio Generic Product Selection Law: influence on pharmacy practice.
    Hunter RH
    Med Mark Media; 1979 Jul; 14(7):33-6. PubMed ID: 10243269
    [No Abstract]   [Full Text] [Related]  

  • 6. Physicians' attitudes toward and knowledge about generic drug substitution.
    Friedman D; Jaffe A; Steinhardt S
    N Y State J Med; 1987 Oct; 87(10):539-42. PubMed ID: 3479720
    [No Abstract]   [Full Text] [Related]  

  • 7. Attitudes of pharmacists and physicians toward Florida's drug product selection law.
    Vuturo GJ; McCormick WC; Krischer JP
    Contemp Pharm Pract; 1980; 3(3):156-62. PubMed ID: 10247871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generic warfarin: implications for clinical practice and perceptions of anticoagulation providers.
    Bongiorno RA; Nutescu EA
    Semin Thromb Hemost; 2004 Dec; 30(6):619-26. PubMed ID: 15630667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating community pharmacists' perceptions of future generic substitution policy implementation: a national survey from Malaysia.
    Chong CP; Hassali MA; Bahari MB; Shafie AA
    Health Policy; 2010 Jan; 94(1):68-75. PubMed ID: 19762106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the northern state of Malaysia.
    Chua GN; Hassali MA; Shafie AA; Awaisu A
    Health Policy; 2010 May; 95(2-3):229-35. PubMed ID: 20044165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Representative sample survey on factors determining the Czech physicians' awareness of generic drugs and substitution.
    Maly J; Zimcikova E; Babica J; Kubena AA; Kostriba J; Mala-Ladova K
    BMC Health Serv Res; 2019 Oct; 19(1):777. PubMed ID: 31666059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generic substitutions: a 2005 survey of the acceptance and perceptions of physicians in Jamaica.
    Gossell-Williams M
    West Indian Med J; 2007 Oct; 56(5):458-63. PubMed ID: 18303760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generic drugs and the prescribing physician.
    Nightingale SL; Morrison JC
    JAMA; 1987 Sep; 258(9):1200-4. PubMed ID: 3626003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of competition on prescription-drug-product substitution.
    Kralewski JE; Pitt L; Dowd B
    N Engl J Med; 1983 Jul; 309(4):213-6. PubMed ID: 6866035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug product selection: the Florida experience.
    Vuturo GJ; Krischer JP; McCormick WC
    Am J Public Health; 1980 May; 70(5):479-84. PubMed ID: 7377418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A generic drug primer: regulatory aspects and scientific concepts.
    Henderson JD; White GL
    Mil Med; 1998 Apr; 163(4):193-7. PubMed ID: 9575760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Forces and direction of drug product selection legislation.
    Stewart JE
    Med Mark Media; 1979 Jun; 14(6):34-6, 38-9. PubMed ID: 10242281
    [No Abstract]   [Full Text] [Related]  

  • 18. Exploring factors underlying the attitude of community pharmacists to generic substitution: a nationwide study from Poland.
    Drozdowska A; Hermanowski T
    Int J Clin Pharm; 2016 Feb; 38(1):162-70. PubMed ID: 26620450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic substitution practices in short-term hospitals.
    Doering PL; Klapp DL; McCormick WC; Russell WL
    Am J Hosp Pharm; 1982 Jun; 39(6):1028-32. PubMed ID: 7102686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of differences in state drug product selection laws on pharmacists' substitution behavior.
    Carroll NV; Fincham JE; Cox FM
    Med Care; 1987 Nov; 25(11):1069-77. PubMed ID: 3695637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.